miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis

Abstract

BackgroundChemokine CXC receptor 4 (CXCR4) in spinal glial cells has been implicated in neuropathic pain. However, the regulatory cascades of CXCR4 in neuropathic pain remain elusive. Here, we investigated the functional regulatory role of miRNAs in the pain process and its interplay with CXCR4 and its downstream signaling.MethodsmiRNAs and CXCR4 and its downstream signaling molecules were measured in the spinal cords of mice with sciatic nerve injury via partial sciatic nerve ligation (pSNL). Immunoblotting, immunofluorescence, immunoprecipitation, and mammal two-hybrid and behavioral tests were used to explore the downstream CXCR4-dependent signaling pathway.ResultsCXCR4 expression increased in spinal glial cells of mice with pSNL-induced neuropathic pain. Blocking CXCR4 alleviated the pain behavior; contrarily, overexpressing CXCR4 induced pain hypersensitivity. MicroRNA-23a-3p (miR-23a) directly bounds to 3′ UTR of CXCR4 mRNA. pSNL-induced neuropathic pain significantly reduced mRNA expression of miR-23a. Overexpression of miR-23a by intrathecal injection of miR-23a mimics or lentivirus reduced spinal CXCR4 and prevented pSNL-induced neuropathic pain. In contrast, knockdown of miR-23a by intrathecal injection of miR-23a inhibitor or lentivirus induced pain-like behavior, which was reduced by CXCR4 inhibition. Additionally, miR-23a knockdown or CXCR4 overexpression in naïve mice could increase the thioredoxin-interacting protein (TXNIP), which was associated with induction of NOD-like receptor protein 3 (NLRP3) inflammasome. Indeed, CXCR4 and TXNIP were co-expressed. The mammal two-hybrid assay revealed the direct interaction between CXCR4 and TXNIP, which was increased in the spinal cord of pSNL mice. In particular, inhibition of TXNIP reversed pain behavior elicited by pSNL, miR-23a knockdown, or CXCR4 overexpression. Moreover, miR-23a overexpression or CXCR4 knockdown inhibited the increase of TXNIP and NLRP3 inflammasome in pSNL mice.ConclusionsmiR-23a, by directly targeting CXCR4, regulates neuropathic pain via TXNIP/NLRP3 inflammasome axis in spinal glial cells. Epigenetic interventions against miR-23a, CXCR4, or TXNIP may potentially serve as novel therapeutic avenues in treating peripheral nerve injury-induced nociceptive hypersensitivity.Electronic supplementary materialThe online version of this article (10.1186/s12974-018-1073-0) contains supplementary material, which is available to authorized users.

Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson's Disease

“…The ATPase activity of NLRP3 is crucial for self‐oligomerization of NLRP3 and its association with ASC, which activates the inflammasome complex . Many NLRP3 inhibitors, such as 3,4‐methylenedioxy‐β‐nitrostyrene (MNS) and BAY 11‐7082, contain a common structural feature, α,β‐unsaturated carbonyl group called Michael acceptors (Table ).…”

“…117 The ATPase activity of NLRP3 is crucial for selfoligomerization of NLRP3 and its association with ASC, which activates the inflammasome complex. 118,119 Many NLRP3 inhibitors, such as 3,4-methylenedioxyβ-nitrostyrene (MNS) and BAY 11-7082, contain a common structural feature, α,β-unsaturated carbonyl group called Michael acceptors (Table 1). These inhibitors selectively inhibit the NLRP3 inflammasome independent of the NF-κB pathway by interacting with its ATPase region in the NACHT domain.…”

Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors

“…Of particular interest is the growing body of evidence that suggests that one member of this pathway (i.e., NOD-like receptor protein 3 (NLRP3)) is involved in various types of neuropathic pain. (Khan et al, 2018;Li et al, 2018;Pan et al, 2018;Pu et al, 2018;Tonkin et al, 2018;Xu et al, 2019) Of note, in a recent preclinical study of PIPN in rats, (Jia et al, 2017) paclitaxel increased the expression of and activated fragments of caspase-1 and IL1β which suggests activation of the NLRP3 inflammasome. The expression of NLRP3 was located in CD68 macrophages that infiltrated the L4-5 DRG and sciatic nerve.…”

NLRP3 inflammasome activation is associated with PM2.5‐induced cardiac functional and pathological injury in mice

“…Once activation is triggered, NLRP3 recruits downstream apoptosis‐associated speck‐like protein contaiining a CARD, cysteine protease caspase‐1 and then assembles NLRP3 inflammasome complex . Subsequently, caspase‐1 precursor (pro‐caspase‐1) is activated into Cleaved caspase‐1 with the formation of p10 and p20 . Meanwhile, active caspase‐1 converts the cytokines pro‐IL‐1β and pro‐IL‐18 into mature and biologically active IL‐1β and IL‐18, triggering the inflammation occurrence .…”